Paul McCormac - Chief Technical Officer at Lexeo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Technical Officer
Stock Symbol
LXEO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Paul McCormac since 9/17/2023

Holdings reported by Paul McCormac for Lexeo Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 17.3K $229K $13.22 Nov 7, 2023 Direct
Series B convertible preferred stock 0 Nov 7, 2023 Direct Common Stock

Transactions reported by Paul McCormac for Lexeo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.